Francesca Yates
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 11
- Chronic Lymphocytic Leukemia Research 11
-
- Lymphoma Diagnosis and Treatment 6
- Co-authors
- Andy C. Rawstron (10 shared papers)Peter Hillmen (8 shared papers)Anna Schuh (4 shared papers)Rebecca H. Boucher (4 shared papers)Kristian Brock (9 shared papers)Donald H. C. Macdonald (5 shared papers)Adrian John Clifton Bloor (8 shared papers)Andrew R. Pettitt (6 shared papers)
- Journals
- Blood (6 papers)British Journal of Haematology (1 paper)Journal of Clinical Oncology (1 paper)BMC Cancer (1 paper)University of Birmingham Research Portal (University of Birmingham) (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
Francesca Yates
11 papers receiving 319 citations
Peers
Comparison fields: 5 of 14
- Genetics 300
- Pathology and Forensic Medicine 193
- Hematology 92
- Immunology 82
- Oncology 35
Countries citing papers authored by Francesca Yates
This map shows the geographic impact of Francesca Yates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Yates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Yates more than expected).
Fields of papers citing papers by Francesca Yates
This network shows the impact of papers produced by Francesca Yates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Yates. The network helps show where Francesca Yates may publish in the future.
Co-authors
The 25 scholars most cited alongside Francesca Yates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 223 | |
| 2 | 2017 | 29 | |
| 3 | 2019 | 26 | |
| 4 | 2020 | 15 | |
| 5 | 2022 | 12 | |
| 6 | 2016 | 11 | |
| 7 | 2020 | 3 | |
| 8 | 2016 | 2 | |
| 9 | The LLR TAP IcICLLe trial assessing biological response to ibrutinib in CLL: Immediate disease redistribution precedes cell cycle arrest by 2 weeks with reduced bone marrow infiltration by 6 months | 2015 | 1 |
| 10 | The LLR TAP IcICLLe Trial: detailed assessment of the response to ibrutinib provides insights into the mode of action and pattern of response in treatment nayve and refractory CLL. | 2015 | 1 |
| 11 | Initial results of ibrutinib plus venetoclax in relapsed, refractory CLL (Bloodwise TAP CLARITY Study): high rates of overall response, complete remission and MRD eradication after 6 months of combination therapy | 2018 | 1 |
About Francesca Yates
Francesca Yates is a scholar working on Genetics, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health, Immunology and Oncology, having authored 11 papers that have together received 324 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Advanced Breast Cancer Therapies (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and Galectins and Cancer Biology (1 paper). The work is most often cited by research in Genetics (300 citations), Pathology and Forensic Medicine (193 citations), Hematology (92 citations), Immunology (82 citations) and Oncology (35 citations). Francesca Yates has collaborated with scholars based in United Kingdom. Frequent co-authors include Andy C. Rawstron, Peter Hillmen, Anna Schuh, Rebecca H. Boucher, Kristian Brock, Donald H. C. Macdonald, Adrian John Clifton Bloor, Andrew R. Pettitt, Christopher Paul Fox and Chris Fegan. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, BMC Cancer and University of Birmingham Research Portal (University of Birmingham).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.